Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence Over Tamoxifen and Further Reduction Is Seen When Combined with Exemestane By Ogkologos - July 6, 2026 71 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SOFT and TEXT studies Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Charity ‘looks to the future with renewed optimism’ July 21, 2021 Cancer Survivor with Strong Family History Was Denied Regular Screening Because... June 30, 2021 Pembrolizumab Demonstrates Robust and Durable Antitumour Activity in Patients with Previously... January 13, 2022 Snowboarder Wins Gold Medal At Winter Olympics After Beating Cancer February 8, 2022 Load more HOT NEWS 2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in... Techniques for Successful Glucose Daddies and Babies Relationships NCI Expands Repository of Cancer Research Models: A Conversation with Drs.... ‘Scandinavian quality and Singaporean efficiency’: what the autumn statement means for...
